BBOT (BRIDGEBIO ONCOLOGY THERAPEUT) Institutional Ownership Summary
Based on the latest SEC 13F filings, 4 institutional investors hold BBOT (BRIDGEBIO ONCOLOGY THERAPEUT) with a combined value of $59.01M across 4,713,045 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $31.68M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 1 fund increased its holdings. 1 fund reduced its position.
Total Institutional Value
$59.01M
Total Shares Held
4,713,045
Institutional Holders
4
Recent Activity
RENAISSANCE TECHNOLOGIES LLCNew Position
Point72 Asset Management, L.P.New Position
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $31.68M | 0.00% | -0.3% |
| 2 | BlackRock, Inc. | $26.10M | 0.00% | +1.8% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $930.24K | 0.00% | New |
| 4 | Point72 Asset Management, L.P. | $295.27K | 0.00% | New |